(Q35106133)

6 August 2017

1 reference

title

The promise of hematopoietic stem cell transplantation for autoimmune diseases (English)

1 reference

6 August 2017

1

Burt RK

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692615

23 December 2023

author name string

Traynor AE

series ordinal

2

1 reference

6 August 2017

Craig R

series ordinal

3

1 reference

6 August 2017

Marmont AM

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://www.nature.com/articles/1703868

1 reference

DOI

10.1038/SJ.BMT.1703868

https://api.crossref.org/works/10.1038/SJ.BMT.1703868

https://www.nature.com/articles/1703868.pdf

23 December 2023

file format

Portable Document Format

1 reference

DOI

10.1038/SJ.BMT.1703868

https://api.crossref.org/works/10.1038/SJ.BMT.1703868

Bone Marrow Transplantation

23 December 2023

published in

1 reference

6 August 2017

31

1 reference

6 August 2017

7

1 reference

6 August 2017

521-524

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703868

6 August 2017

0 references

cites work

Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Stem cell transplantation in experimental models of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Allogeneic stem cell transplantation for Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Hematopoietic stem-cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703868

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703868

1 reference

6 August 2017

1 reference